|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.385 AUD | +1.32% |
|
+2.67% | -6.10% |
| Apr. 15 | Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3% | MT |
| Apr. 09 | Orthocell Revenue Soars 19% to AU$1.61 Million in Q1 | MT |
Orthocell Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 2.3 million compared to AUD 0.056772 million a year ago. Net loss was AUD 6.25 million compared to AUD 9.11 million a year ago.
Basic loss per share from continuing operations was AUD 0.032 compared to AUD 0.047 a year ago. Diluted loss per share from continuing operations was AUD 0.032 compared to AUD 0.047 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.10% | 51.67M | |
| -1.65% | 104B | |
| +6.75% | 97.47B | |
| +5.71% | 22.25B | |
| -12.60% | 21.68B | |
| -9.70% | 18.2B | |
| -39.98% | 17.02B | |
| -10.17% | 16.36B | |
| +6.12% | 14.39B | |
| +35.47% | 12.37B |
ORTHOCELL LIMITED 
